Evidence map›Paper›PMID 41212449›Full record

ArticleJapanese journal of radiology2026

Evaluation of meningeal lymphatic vessels with delayed contrast enhanced vessel-wall MRI in cerebral infarction.

Masaki Umehana, Yasutaka Fushimi, Sachi Okuchi, Sayo Otani, Takayuki Yamamoto, Akihiko Sakata, Satoshi Nakajima, Satoshi Ikeda, Shuichi Ito, John Grinstead and 10 more

Abstract read
In one paragraph

Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Masaki UmehanaDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Yasutaka FushimiDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. yfushimi@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-1982-3168
Sachi OkuchiDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Sayo OtaniDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Takayuki YamamotoDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Akihiko SakataDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Satoshi NakajimaDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Satoshi IkedaDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Shuichi ItoDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
John GrinsteadSiemens Healthineers, Portland, OR, USA.
Sinyeob AhnSiemens Healthineers, San Francisco, CA, USA.
Katsuhiko MitsumotoDepartment of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.
Kentaro UenoDepartment of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Chia-Hung WuDepartment of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Satoshi MiuraDepartment of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takakuni MakiDepartment of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hideo ChiharaDepartment of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takeshi FunakiDepartment of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoshiki ArakawaDepartment of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuji NakamotoDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Funding

Japan Society for the Promotion of Science JP22K07746Japan Society for the Promotion of Science JP24K18796Japan Society for the Promotion of Science JP25K02603Kyoto Technoscience Center Kyoto Technoscience Center
6 · The paper itself

Abstract

purposeObservation of the clearance of gadolinium-based contrast agents (GBCA) in patients with cerebral infarction and Moyamoya disease (MMD) using vessel-wall MRI (VW-MRI).

methodsThis prospective study included 11 patients with recent cerebrovascular disorder and 6 patients with MMD who were scheduled for VW-MRI. All participants underwent whole brain delay alternating with nutation for tailored excitation-prepared T1-weighted variable flip angle turbo spin echo (DANTE T1-SPACE) imaging before, immediately after, and 1-6 h after gadolinium injection. Additionally, a phantom experiment was conducted to assess the signal intensity according to T1 values using DANTE T1-SPACE and 3D real inversion recovery sequences.

resultsAll five large infarction cases (≥ 5 cm) had delayed meningeal enhancement on the ipsilateral side, while none of the remaining six small infarction cases (< 5 cm) exhibited delayed meningeal enhancement on MRI. More than half of the entire cases had delayed white matter enhancement adjacent to the infarction. No MMD cases showed delayed enhancement outside postoperative regions. In the phantom experiment, DANTE T1-SPACE (TR = 700-1300 ms) demonstrated stable signal intensity across a T1 range of approximately 500-1000 ms. This T1 range corresponds to signal intensity ≈ 200-600 typically observed in regions showing delayed enhancement in clinical stroke and MMD cases.

conclusionsDelayed meningeal enhancement observed in patients with large cerebral infarctions likely reflects alterations in brain clearance pathways. The absence of such enhancement in MMD supports that these enhancements are not attributable to collateral circulation. Phantom validation confirmed that the imaging parameters used in the DANTE T1-SPACE sequence were sufficient to detect subtle contrast enhancement in the clinically relevant T1 range.

Indexed as

Cerebral InfarctionContrast MediaImage EnhancementMagnetic Resonance ImagingMeningesMoyamoya DiseaseAdultAgedFemaleHumansMaleMiddle AgedPhantoms, ImagingProspective StudiesContrast MediaGlymphatic systemIntramural periarterial drainageMeningeal lymphatic vesselsStrokeVessel-wall MRI

Identifiers

PMID41212449
PMCPMC12948836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.